StockTipsArenaBeta

BUY Gland Pharma Limited — Vishnu Kant Upadhyay, Master Capital Services

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byVishnu Kant Upadhyay, Master Capital ServicesHorizon: 1–3 months13 Oct 2026via LiveMint Markets

Entry₹3,078.4Inferred
Target₹3,400
Total upside +10.45%
Stop lossNot given
CMP₹3,066.33h ago
Active-0.39%+10.88%upside left 3 mo left
Follow Vishnu Kant Upadhyay for new calls(26% target hit, 50 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 4 other Short-term calls on GLANDSee 71 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Oct, 7:38 pm IST
7 supporting1 neutral1 opposing
Supports the BUY call (7)

MACD above its signal line — bullish momentum

Technicals · macd·15 Oct · today

7 advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·7 Oct · 1w ago

4 other SEBI-registered advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·7 Oct · 1w ago

Gland Pharma sets e-voting for Wang appointment; $21m US investment approved

NewsGoogle News·6 Oct · 1w ago

(opens in new tab)

Gland Pharma to invest $21 million in US drugmaker, take 60% stake

NewsCnbc-Tv18·1 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (1)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

2 advisors have active long-term SELL calls on this stock

Advisor consensus · adjacent horizon·12 Aug · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Vishnu Kant Upadhyay, Master Capital Services

Every call and its outcome